Skip to main content

Novo Holdings A/S

In the past year, 2 open-market purchase filings worth $26.2M and no sales.

Current role at each company

Show 9 more companies

Open-market trades in the past year

Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.

Bought
$26.2M
2 filings
Sold
–
0 filings
Net
+$26.2M
Bought minus sold
Companies
2
With open-market trades

Trades

Every Form 4 that lists Novo Holdings A/S as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.

AVLN Avalyn Pharma Inc.

10% Owner1 trade

Insider trades
Filed (ET)Trade dateFiling delayInsiderTransactionSharesAvg priceValueHolding changeFlags
May 5, 2026 (view filing)May 14 daysNovo Holdings A/S10% OwnerPPurchaseVoting Common Stock+555.6K$18.00+$10.0M+16.7%3.88M after

MPLT MapLight Therapeutics, Inc.

10% Owner1 trade

Insider trades
Filed (ET)Trade dateFiling delayInsiderTransactionSharesAvg priceValueHolding changeFlags
Oct 30, 2025 (view filing)Oct 282 daysNovo Holdings A/S10% OwnerPPurchaseVoting Common Stock+952.9K$17.00+$16.2M+34.9%3.69M after

IOBT IO Biotech, Inc.

10% Owner6 trades

Insider trades
Filed (ET)Trade dateFiling delayInsiderTransactionSharesAvg priceValueHolding changeFlags
Jul 26, 2024 (view filing)Jul 25-261 dayNovo Holdings A/S10% OwnerSSale−75.0K$1.32−$99.3K−1.7%4.35M after2 lots
May 14, 2024 (view filing)May 104 daysNovo Holdings A/S10% OwnerSSale−658.8K$1.22−$803.7K−12.9%4.43M after
Feb 13, 2024 (view filing)Feb 94 daysNovo Holdings A/S10% OwnerSSale−658.8K$1.50−$988.2K−11.5%5.09M after
Aug 11, 2023 (view filing)Aug 92 daysNovo Holdings A/S10% OwnerPPurchase+2.47M$2.03+$5.01M+76.2%5.71M after
Aug 11, 2023 (view filing)Aug 92 daysNovo Holdings A/S10% OwnerPPurchase+2.47M$2.03+$5.01M–2.47M afterDerivative
Nov 10, 2021 (view filing)Nov 91 dayNovo Holdings A/S10% OwnerPPurchase+325.0K$14.00+$4.55M+11.0%3.28M after

SPRB Spruce Biosciences, Inc.

10% Owner5 trades

Insider trades
Filed (ET)Trade dateFiling delayInsiderTransactionSharesAvg priceValueHolding changeFlags
Mar 25, 2024 (view filing)Mar 214 daysNovo Holdings A/S10% OwnerSSale−465.0K$0.75−$348.8K−15.4%2.55M after
Mar 20, 2024 (view filing)Mar 18-202 daysNovo Holdings A/S10% OwnerSSale−1.79M$0.7587−$1.36M−37.3%3.02M after3 lots
Mar 18, 2024 (view filing)Mar 144 daysNovo Holdings A/S10% OwnerSSale−1.91M$0.89−$1.70M−28.4%4.81M after
Feb 21, 2023 (view filing)Feb 165 daysNovo Holdings A/S10% OwnerPPurchase+2.21M$3.17+$7.00M+48.9%6.72M after
Feb 21, 2023 (view filing)Feb 165 daysNovo Holdings A/S10% OwnerPPurchase+1.66M–––1.66M afterDerivative

MGX Metagenomi Therapeutics, Inc.

10% Owner1 trade

Insider trades
Filed (ET)Trade dateFiling delayInsiderTransactionSharesAvg priceValueHolding changeFlags
Feb 15, 2024 (view filing)Feb 9-136 daysLateNovo Holdings A/S10% OwnerPPurchase+900.0K$14.47+$13.0M+107.2%1.74M after2 lots

CYT Cyteir Therapeutics, Inc.

10% Owner8 trades

Insider trades
Filed (ET)Trade dateFiling delayInsiderTransactionSharesAvg priceValueHolding changeFlags
Jul 20, 2023 (view filing)Jul 19-201 dayNovo Holdings A/S10% OwnerSSale−101.9K$2.75−$280.2K−2.8%3.52M after2 lots
Jul 18, 2023 (view filing)Jul 14-184 daysNovo Holdings A/S10% OwnerSSale−38.6K$2.75−$106.1K−1.1%3.62M after3 lots
Jul 3, 2023 (view filing)Jun 303 daysNovo Holdings A/S10% OwnerSSale−200.9K$2.63−$528.5K−5.2%3.66M after
Jun 28, 2023 (view filing)Jun 26-272 daysNovo Holdings A/S10% OwnerSSale−40.4K$1.77−$71.7K−1.0%3.86M after2 lots
Jun 23, 2023 (view filing)Jun 21-232 daysNovo Holdings A/S10% OwnerSSale−13.3K$1.94−$25.8K−0.3%3.90M after3 lots
Jun 20, 2023 (view filing)Jun 15-205 daysNovo Holdings A/S10% OwnerSSale−16.7K$2.03−$34.0K−0.4%3.92M after3 lots
Jun 14, 2023 (view filing)Jun 12-142 daysNovo Holdings A/S10% OwnerSSale−6.40K$2.10−$13.4K−0.2%3.93M after3 lots
Jul 22, 2022 (view filing)Jul 202 daysNovo Holdings A/S10% OwnerSSale−900.0K$3.00−$2.70M−18.6%3.94M after

IRON Disc Medicine, Inc.

10% Owner1 trade

Insider trades
Filed (ET)Trade dateFiling delayInsiderTransactionSharesAvg priceValueHolding changeFlags
Jun 28, 2023 (view filing)Jun 28Same dayNovo Holdings A/S10% OwnerSSale−1.25M$46.10−$57.6M−53.4%1.09M after

OKUR OnKure Therapeutics, Inc.

10% Owner1 trade

Insider trades
Filed (ET)Trade dateFiling delayInsiderTransactionSharesAvg priceValueHolding changeFlags
Jun 23, 2023 (view filing)Jun 23Same dayNovo Holdings A/S10% OwnerSSale−100.0K$7.10−$710.0K−2.9%3.33M after

EWTX Edgewise Therapeutics, Inc.

10% Owner1 trade

Insider trades
Filed (ET)Trade dateFiling delayInsiderTransactionSharesAvg priceValueHolding changeFlags
Sep 16, 2022 (view filing)Sep 142 daysNovo Holdings A/S10% OwnerPPurchase+484.5K$10.32+$5.00M+8.7%6.07M after

BOLT Bolt Biotherapeutics, Inc.

10% Owner1 trade

Insider trades
Filed (ET)Trade dateFiling delayInsiderTransactionSharesAvg priceValueHolding changeFlags
Jul 15, 2022 (view filing)Jul 132 daysNovo Holdings A/S10% OwnerSSale−800.0K$2.00−$1.60M−17.8%3.70M after

CMPI Checkmate Pharmaceuticals, Inc.

10% Owner1 trade

Insider trades
Filed (ET)Trade dateFiling delayInsiderTransactionSharesAvg priceValueHolding changeFlags
Feb 25, 2022 (view filing)Feb 23-252 daysNovo Holdings A/S10% OwnerSSale−8.11K$2.84−$23.0K−0.4%2.16M after3 lots

ACLX Arcellx, Inc.

10% Owner1 trade

Insider trades
Filed (ET)Trade dateFiling delayInsiderTransactionSharesAvg priceValueHolding changeFlags
Feb 9, 2022 (view filing)Feb 81 dayNovo Holdings A/S10% OwnerPPurchase+833.3K$15.00+$12.5M+26.2%4.02M after

UTRS Minerva Surgical Inc

10% Owner1 trade

Insider trades
Filed (ET)Trade dateFiling delayInsiderTransactionSharesAvg priceValueHolding changeFlags
Oct 27, 2021 (view filing)4:31 PM ETOct 261 dayNovo Holdings A/S10% OwnerPPurchase+580.0K$12.00+$6.96M+39.3%2.06M after